Indivior Pharmaceuticals Inc
INDV
株式のランク
#3875
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
株価
$34.27
時価総額
$4.28B
変化（1日）
1.18%
変化（1年）
41.09%
国
US
取引 Indivior Pharmaceuticals Inc (INDV)
カテゴリー
Healthcare
Indivior Pharmaceuticals Inc（INDV）のP/B比率
October 2026 時点のP/B比率 TTM: -20.59
Indivior Pharmaceuticals Inc の最新の財務報告および株価によると、現在のP/B比率（TTM）は -20.59 です。2023 年末時点でのP/B比率は 31.28 でした。
Indivior Pharmaceuticals Inc の P/B 比率の履歴（2016 ～ 2026）
各年末時点のP/B比率
| 年 | P/B比率 | 変化 |
|---|---|---|
| 2026 (TTM) | -20.59 | 337.08% |
| 2024 | -4.71 | -115.07% |
| 2023 | 31.28 | -46.95% |
| 2022 | 58.97 | 375.46% |
| 2021 | 12.40 | -5.60% |
| 2020 | 13.14 | 623.09% |
| 2019 | 1.82 | -87.78% |
| 2018 | 14.87 | -176.13% |
| 2017 | -19.54 | 125.54% |
| 2016 | -8.66 | 0.00% |
同業他社のP/B比率
| 企業 | P/B比率 | P/B比率の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -124.49% |
IN
|
